EUVIMEDEUVIMED entdecken
Crossref

Does Intermediate Molecular Risk Really Justify Total Thyroidectomy?

Fernanda Vaisman

Clinical Thyroidology® · 01.11.2026 · 38 (11) · 398-401

DOI: 10.1177/23299711261506100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 16.11.2026. Verfasst von Fernanda Vaisman. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vaisman, F. (2026). Does Intermediate Molecular Risk Really Justify Total Thyroidectomy?. Clinical Thyroidology®, 38(11), 398-401. https://doi.org/10.1177/23299711261506100

Vancouver

Vaisman F. Does Intermediate Molecular Risk Really Justify Total Thyroidectomy?. Clinical Thyroidology®. 2026;38(11):398-401. doi:10.1177/23299711261506100

BibTeX
@article{Vaisman2026,
  author = {Vaisman, Fernanda},
  title = {Does Intermediate Molecular Risk Really Justify Total Thyroidectomy?},
  journal = {Clinical Thyroidology®},
  year = {2026},
  volume = {38},
  number = {11},
  pages = {398--401},
  doi = {10.1177/23299711261506100}
}
Kostenlos starten →